2026-08-01
Antibody ALMB-0166 Calms Overactive Astrocytes — Safety and Early Signals from a First-in-Human Trial in Spinal Cord Injury
ALMB-0166, the first Cx43-hemichannel antibody, given as a single dose to 24 SCI patients: adverse events matched placebo, 1200/2400mg improved scores, two reached AIS E. A small, exploratory result.
解説を読む →
